GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
The Department of Homeland Security (DHS) on Friday pushed back against accusations from Arizona Democratic Rep. Adelita Grijalva, who claimed she was pepper sprayed during an immigration raid in Tucs...
Hungary has blocked the issuance of Eurobonds to arm Ukraine, Politico reports...
The driver, Luis Torres Mujica, 30, a resident of Guanajuato, and his passenger, Jesse Joe Camacho, 28, of McAllen, Texas, were arrested and charged with theft of property and firearm smuggling, a sec...
